» Articles » PMID: 2417757

Quantitation of Apolipoprotein B by Polyclonal and Monoclonal Antibodies

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 1986 Jan 15
PMID 2417757
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A non-competitive sandwich enzyme linked immunosorbent assay for the quantitation of apolipoprotein B with polyclonal and monoclonal antibodies was developed. Polyclonal antibodies were used as 'coater'. In the assay with polyclonal antibodies, the same antibody was used as conjugate with alkaline phosphatase. For studies with monoclonal antibodies, enzyme conjugated anti-mouse immunoglobulin had to be used, since monoclonal antibodies lost their reactivity upon enzyme conjugation. Two murine monoclonal antibodies were employed: MAB B-1 with specificity for apolipoproteins (Apo) B-48 and B-100 and MAB B-5 with specificity for B-100 (Radioimmunoassay Inc.). In a reference group Apo B values of 0.82 +/- 0.20 g/l were measured with polyclonal antibodies, 0.68 +/- 0.19 g/l and 0.95 +/- 0.33 g/l with MAB B-1 and MAB B-5. In pure hypercholesterolemia, a similar increase was found with all three antibodies, while in combined hyperlipoproteinemia MAB B-5 gave greater than 40% lower values. Differences were also found with respect to the correlation between Apo B and cholesterol or triglycerides.

Citing Articles

ELISA quantitation of apolipoproteins in plasma lipoprotein fractions: ApoE in ApoB-containing lipoproteins (Lp B:E) and ApoB in ApoE-containing lipoproteins (Lp E:B).

Yang C, Xie Y, Yang M, Quion J, Gotto Jr A J Protein Chem. 1995; 14(7):503-9.

PMID: 8561846 DOI: 10.1007/BF01886876.


Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II.

Saxenhofer H, Weidmann P, Riesen W, Fragiacomo C, Wunderlin R, Noseda G Eur J Clin Pharmacol. 1990; 39(2):101-5.

PMID: 2123791 DOI: 10.1007/BF00280040.


Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.

Ferrier C, Ferrari P, Weidmann P, Keller U, Riesen W Drugs. 1992; 44 Suppl 1:74-84.

PMID: 1283588 DOI: 10.2165/00003495-199200441-00014.